Daniela Molena1, Benedetto Mungo2, Miloslawa Stem3, Amy K Poupore3, Sophia Y Chen3, Anne O Lidor3. 1. Division of Thoracic Surgery, Department of Surgery, Johns Hopkins University School of Medicine, 600 N Wolfe Street, Blalock 240, Baltimore, MD, 21287, USA. dmolena2@jhmi.edu. 2. Division of Thoracic Surgery, Department of Surgery, Johns Hopkins University School of Medicine, 600 N Wolfe Street, Blalock 240, Baltimore, MD, 21287, USA. 3. Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Abstract
INTRODUCTION: The aim of this study was to assess whether adherence to National Comprehensive Cancer Network (NCCN) guidelines leads to differences in survival in patients diagnosed with locally advanced esophageal cancer. METHODS: This is a retrospective cohort study of patients with stage II and III esophageal cancer included in the Cancer Registry at the Sidney Kimmel Comprehensive Cancer Center at the Johns Hopkins Hospital from 2008 to 2013. Seven quality indicators were identified using the 2014 NCCN guidelines, and individual and overall quality measure scores were calculated and used to define low and high quality of care groups. RESULTS: One hundred forty-one patients met inclusion criteria, and 88 patients (62.4 %) were identified as receiving high-quality care. Adherence to guidelines ranged from 63.1 to 100.0 %, with an overall compliance of 81.3 %. Risk factors for receiving low quality of care included advanced age, non-white race, lower education level, and unspecified primary site of tumor. A significantly better overall survival was observed in patients who received high-quality care (HR, 0.58; 95 %, 0.37-0.90, p = 0.015). CONCLUSIONS: Delivery of high-quality care is associated with improved survival in these patients. Efforts should be directed at minimizing disparities in treatment in regards to race and educational levels.
INTRODUCTION: The aim of this study was to assess whether adherence to National Comprehensive Cancer Network (NCCN) guidelines leads to differences in survival in patients diagnosed with locally advanced esophageal cancer. METHODS: This is a retrospective cohort study of patients with stage II and III esophageal cancer included in the Cancer Registry at the Sidney Kimmel Comprehensive Cancer Center at the Johns Hopkins Hospital from 2008 to 2013. Seven quality indicators were identified using the 2014 NCCN guidelines, and individual and overall quality measure scores were calculated and used to define low and high quality of care groups. RESULTS: One hundred forty-one patients met inclusion criteria, and 88 patients (62.4 %) were identified as receiving high-quality care. Adherence to guidelines ranged from 63.1 to 100.0 %, with an overall compliance of 81.3 %. Risk factors for receiving low quality of care included advanced age, non-white race, lower education level, and unspecified primary site of tumor. A significantly better overall survival was observed in patients who received high-quality care (HR, 0.58; 95 %, 0.37-0.90, p = 0.015). CONCLUSIONS: Delivery of high-quality care is associated with improved survival in these patients. Efforts should be directed at minimizing disparities in treatment in regards to race and educational levels.
Entities:
Keywords:
Esophageal cancer; NCCN guidelines; Quality of care; Survival
Authors: Alexander J Greenstein; Virginia R Litle; Scott J Swanson; Celia M Divino; Stuart Packer; Thomas G McGinn; Juan P Wisnivesky Journal: Ann Surg Oncol Date: 2007-11-07 Impact factor: 5.344
Authors: Matthew D Taylor; Damien J LaPar; John P Davis; James M Isbell; Benjamin D Kozower; Christine L Lau; David R Jones Journal: Ann Thorac Surg Date: 2013-04-22 Impact factor: 4.330
Authors: David J Worhunsky; Yifei Ma; Yulia Zak; George A Poultsides; Jeffrey A Norton; Kim F Rhoads; Brendan C Visser Journal: J Natl Compr Canc Netw Date: 2015-03 Impact factor: 11.908
Authors: Christine G Gourin; Kevin D Frick; Amanda L Blackford; Robert J Herbert; Harry Quon; Arlene A Forastiere; David W Eisele; Sydney M Dy Journal: Laryngoscope Date: 2014-02-22 Impact factor: 3.325
Authors: Sha'Shonda L Revels; Mousumi Banerjee; Huiying Yin; Christopher J Sonnenday; John D Birkmeyer Journal: J Am Coll Surg Date: 2012-11-27 Impact factor: 6.113
Authors: Samantha L Quaife; Kelly Winstanley; Katie A Robb; Alice E Simon; Amanda J Ramirez; Lindsay J L Forbes; Kate E Brain; Anna Gavin; Jane Wardle Journal: Eur J Cancer Prev Date: 2015-05 Impact factor: 2.497
Authors: Rachel K Voss; Yi-Ju Chiang; Keila E Torres; B Ashleigh Guadagnolo; Gary N Mann; Barry W Feig; Janice N Cormier; Christina L Roland Journal: Ann Surg Oncol Date: 2017-07-24 Impact factor: 5.344
Authors: Rolfy A Perez Holguin; Elizabeth J Olecki; Kelly A Stahl; William G Wong; Charles C Vining; Matthew E B Dixon; June S Peng Journal: J Gastrointest Surg Date: 2022-08-30 Impact factor: 3.267
Authors: R Costas-Muniz; J Amir; M Paris; D Spratt; J Arevalo-Perez; S Fareedy; C J González; F Gany; M Camacho-Rivera; J R Osborne Journal: J Community Med Health Educ Date: 2017-02-20
Authors: Aaron M Delman; Allison M Ammann; Kevin M Turner; Dennis M Vaysburg; Robert M Van Haren Journal: J Thorac Dis Date: 2021-06 Impact factor: 2.895